Nippon Life Global Investors Americas’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.81M | Sell |
4,470
-13,660
| -75% | -$5.54M | 0.08% | 76 |
|
2025
Q1 | $9.03M | Sell |
18,130
-53,090
| -75% | -$26.4M | 0.44% | 51 |
|
2024
Q4 | $37.1M | Sell |
71,220
-26,300
| -27% | -$13.7M | 1.71% | 18 |
|
2024
Q3 | $60.4M | Buy |
97,520
+14,890
| +18% | +$9.22M | 2.59% | 11 |
|
2024
Q2 | $45.7M | Buy |
82,630
+1,440
| +2% | +$797K | 2.01% | 16 |
|
2024
Q1 | $47.2M | Buy |
81,190
+10,580
| +15% | +$6.15M | 2.2% | 13 |
|
2023
Q4 | $37.5M | Sell |
70,610
-3,110
| -4% | -$1.65M | 2.09% | 13 |
|
2023
Q3 | $37.3M | Buy |
73,720
+13,340
| +22% | +$6.76M | 2.3% | 9 |
|
2023
Q2 | $31.5M | Sell |
60,380
-8,430
| -12% | -$4.4M | 2.14% | 10 |
|
2023
Q1 | $39.7M | Buy |
68,810
+26,930
| +64% | +$15.5M | 2.54% | 8 |
|
2022
Q4 | $23.1M | Sell |
41,880
-340
| -0.8% | -$187K | 1.52% | 23 |
|
2022
Q3 | $21.4M | Buy |
42,220
+14,440
| +52% | +$7.33M | 1.51% | 18 |
|
2022
Q2 | $15.1M | Buy |
27,780
+2,830
| +11% | +$1.54M | 0.98% | 33 |
|
2022
Q1 | $14.7M | Sell |
24,950
-1,480
| -6% | -$874K | 0.79% | 39 |
|
2021
Q4 | $17.6M | Hold |
26,430
| – | – | 0.83% | 33 |
|
2021
Q3 | $15.1M | Buy |
+26,430
| New | +$15.1M | 0.79% | 35 |
|
2017
Q3 | – | Sell |
-31,860
| Closed | -$5.56M | – | 151 |
|
2017
Q2 | $5.56M | Sell |
31,860
-10,180
| -24% | -$1.78M | 0.48% | 73 |
|
2017
Q1 | $6.46M | Buy |
42,040
+6,540
| +18% | +$1M | 0.58% | 60 |
|
2016
Q4 | $5.01M | Buy |
35,500
+2,510
| +8% | +$354K | 0.46% | 80 |
|
2016
Q3 | $5.25M | Hold |
32,990
| – | – | 0.49% | 74 |
|
2016
Q2 | $4.87M | Buy |
+32,990
| New | +$4.87M | 0.47% | 76 |
|
2013
Q3 | – | Sell |
-63,840
| Closed | -$5.4M | – | 143 |
|
2013
Q2 | $5.4M | Buy |
+63,840
| New | +$5.4M | 0.6% | 72 |
|